BioAge Labs, Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | 2.4% | – | 2.2% | 2.3% | – | – | |
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 97.7% | 100.0% | 99.4% | |
| – | – | – | – | – | – | 765.6% | 822.7% | 901.3% | 796.0% | 736.3% | 994.1% | 847.8% | |
| – | – | – | – | – | – | 467.8% | 304.3% | 325.3% | 227.5% | 279.1% | 302.7% | 278.5% | |
| – | – | – | – | – | – | 1,233.4% | 1,127.0% | 1,226.6% | 1,023.4% | 1,013.1% | 1,296.8% | 1,125.7% | |
| – | – | – | – | – | – | -1,133.4% | -1,027.0% | -1,126.6% | -923.4% | -915.4% | -1,196.8% | -1,026.3% | |
| – | – | – | – | – | – | 17.6% | 8.3% | 7.3% | 3.0% | 1.4% | 0.0% | 2.7% | |
| – | – | – | – | – | – | -891.0% | -894.0% | -982.0% | -842.9% | -802.8% | -1,064.7% | -912.3% | |
| – | – | – | – | – | – | -891.0% | -894.0% | -982.0% | -842.9% | -802.8% | -1,064.7% | -912.3% | |
| – | – | – | – | – | – | -870.8% | -883.3% | -972.4% | -837.6% | -799.1% | -1,061.9% | -907.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.